Orthofix International N.v Stock News

New York, USA, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Global Orthobiologics Market is Anticipated to Grow at a CAGR of 4.44% During the Forecast Period (2021-26) | DelveInsight As per DelveInsight analysis, a growing geriatric population at risk of developing various bone degenerative disorders, an increase in traumatic injuries such as car accidents, sports injuries, and others are expected to boost the Orthobiologics market growth. Furthermore rising investments in R&D and collaborations by key manufacturers, as well as an increase in various orthobiologic product approvals will also drive the market. DelveInsight''s Orthobiologics Market Insights and Forecast report provides the current and forecast Orthobiologics market, upcoming developments in the medical devices, individual market shares, challenges, drivers, barriers, market growth trends, and key players in the Orthobiologics market. Some of the Key Highlights from the Orthobiologics Market Report According to DelveInsight analysis, North America is expected to dominate the overall Orthobiologics Market during the forecasted period.

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that it plans to release financial results for the fourth quarter and full year 2021 before market open on Friday, February 25, 2022. Jon Serbousek, President and Chief Executive Officer, and Doug Rice, Chief Financial Officer, will host a conference call and webcast to review the Companys results at 8:30 a.m. ET the same day. Interested p

Orthofix Medical <> jumps after reporting 6% Y/Y growth of its fourth quarter preliminary revenue to $125M vs

Oakview Capital Management L.P. cut its holdings in shares of Orthofix Medical Inc. (NASDAQ:OFIX) by 4.9% during the 3rd quarter, Holdings Channel.com reports. The firm owned 292,947 shares of the medical device companys stock after selling 15,061 shares during the quarter. Orthofix Medical comprises approximately 3.8% of Oakview Capital Management L.P.s holdings, making the stock []

Parametric Portfolio Associates LLC increased its position in shares of Orthofix Medical Inc. (NASDAQ:OFIX) by 2.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 56,673 shares of the medical device companys stock after buying an additional 1,554 shares during the period. []

Morgan Stanley lifted its position in shares of Orthofix Medical Inc. (NASDAQ:OFIX) by 104.5% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 98,790 shares of the medical device companys stock after buying an additional 50,491 shares during the quarter. Morgan Stanleys holdings in Orthofix Medical were worth $3,961,000 at the end of the []

Analysts forecast that Orthofix Medical Inc. (NASDAQ:OFIX) will announce earnings per share (EPS) of $0.12 for the current quarter, according to Zacks. Two analysts have issued estimates for Orthofix Medicals earnings, with the lowest EPS estimate coming in at $0.11 and the highest estimate coming in at $0.13. Orthofix Medical reported earnings of $0.44 per []

Hillsdale Investment Management Inc. bought a new stake in Orthofix Medical Inc. (NASDAQ:OFIX) during the third quarter, HoldingsChannel.com reports. The fund bought 103,200 shares of the medical device companys stock, valued at approximately $3,934,000. A number of other large investors have also recently added to or reduced their stakes in OFIX. Marshall Wace North America []

Orthofix Medical (NASDAQ:OFIX) was upgraded by Zacks Investment Research from a sell rating to a hold rating in a research report issued on Saturday, Zacks.com reports. According to Zacks, Orthofix Medical Inc. develops, produces and markets medical devices. The Company offers spine fixation, biological and other orthopedic and spine solutions. Orthofix Medical Inc., formerly known []

Wall Street brokerages expect that Orthofix Medical Inc. (NASDAQ:OFIX) will post $122.55 million in sales for the current quarter, according to Zacks. Two analysts have made estimates for Orthofix Medicals earnings. The lowest sales estimate is $122.50 million and the highest is $122.60 million. Orthofix Medical reported sales of $117.62 million during the same quarter []

Metropolitan Life Insurance Co NY increased its position in shares of Orthofix Medical Inc. (NASDAQ:OFIX) by 101,400.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,090 shares of the medical device companys stock after acquiring an additional 6,084 shares []

Thrivent Financial for Lutherans lowered its position in shares of Orthofix Medical Inc. (NASDAQ:OFIX) by 23.0% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 24,719 shares of the medical device companys stock after selling 7,372 shares during the period. Thrivent Financial for Lutherans owned 0.13% of Orthofix []

Orthofix Medical Inc. (NASDAQ:OFIX) Director Catherine M. Burzik acquired 1,660 shares of Orthofix Medical stock in a transaction that occurred on Friday, November 19th. The shares were purchased at an average price of $30.27 per share, for a total transaction of $50,248.20. The acquisition was disclosed in a filing with the SEC, which is available []

Charles Schwab Investment Management Inc. lifted its position in Orthofix Medical Inc. (NASDAQ:OFIX) by 6.2% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 179,025 shares of the medical device companys stock after purchasing an additional 10,527 shares during the []

Orthofix Medical (NASDAQ:OFIX) and SANUWAVE Health (OTCMKTS:SNWV) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, dividends, risk and institutional ownership. Analyst Ratings This is a breakdown of recent ratings and target prices for Orthofix Medical []